Beta-pyridylcarbinol (RonicolR) releases a prostacyclin-like substance into arterial blood of patients with arteriosclerosis obliterans
- 1 April 1983
- journal article
- research article
- Published by Elsevier in Pharmacological Research Communications
- Vol. 15 (4) , 377-385
- https://doi.org/10.1016/s0031-6989(83)80047-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Prostacyclin and blood glucose levels in humans and rabbitsProstaglandins, 1981
- Prostacyclin release and the modulation of some vasoactive hormonesProstaglandins, 1980
- SUCCESSFUL THERAPY OF ADVANCED ARTERIOSCLEROSIS OBLITERANS WITH PROSTACYCLINThe Lancet, 1979
- Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbitsAtherosclerosis, 1978
- Generation of prostacyclin by lungs in vivo and its release into the arterial circulationNature, 1978
- Nicotinic acid inhibits thromboxane synthesis in plateletsProstaglandins, 1978
- Reversal of platelet aggregation by prostacyclinPharmacological Research Communications, 1978
- The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbitsProstaglandins, 1977
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- Behandlung primärer Hyperlipoproteinämien der Typen IIa, IIb und IV mit β-PyridylcarbinolDeutsche Medizinische Wochenschrift (1946), 1973